Skip to main content
. 2021 Apr 16;12:649475. doi: 10.3389/fimmu.2021.649475

Figure 8.

Figure 8

Characterization of GSK-3β and p70S6K involvement in Mtb-mediated cytokine production during rapamycin treatment of human DC. (A) DC were left unstimulated (CTRL) or infected for 24 h with Mtb alone (MTB) or in combination with rapamycin added 4 h post infection (MTB+RAPA), with or without the GSK-3β (SB216763) or the p70S6K (PF4708671) inhibitors. IL-12, IL-1β, TNF-α, IL-6 and IL-10 production was evaluated by Inflammatory Cytokine bead array kit, while IL-23 release was measured by ELISA. (B) DC were transfected with 100 nM of siRNA specific for GSK-3β (iGSK-3β) or with a control siRNA (neg ctrl) for 8 h and then left unstimulated (CTRL) or infected for 24 h with Mtb alone or in combination with rapamycin. Cytokine amount was determined as in (A). The results represent mean values ± standard error of 4 independent experiments. Significance was calculated by analysis of variance (ANOVA) followed by multiple comparison performed with Tukey’s test as specified in Materials and Methods section.